Bioceres Files for IPO
Bioceres has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Archive
Year: 2015
All Year: 2015 Articles
Newest first · Page 158Chicago Fed Shows Slowing National Economic Trends for August
The Chicago Fed National Activity Index said that the August drop was led by declines in production-related indicators.
What Does the Emissions Scandal Mean for the German Economy?
Is BMW involved in a emissions scandal of its own? One German newspaper claims yes, that emissions on BMW diesel cars are much higher than advertised.
Weekly Jobless Claims Keep Running Low and Within Expectations
The U.S. economy now has seen about seven straight months in which weekly jobless claims have come in under 300,000.
New Home Sales Post 7-Year High in August
The U.S. Census Bureau and the Department of Housing and Urban Development reported Tuesday morning that sales of new homes in August rose to a seasonally adjusted annual rate of 552,000, an increase of…
Durable Goods Tick Lower in August
New orders for durable goods were not all that durable in August. The only good news here is that the drop was not as bad as economists had expected.
How the Volkswagen Scandal Is Crushing Platinum
The scandal swirling around Volkswagen will inevitably have an impact on other diesel vehicle makers. That is not good news for platinum.
Natural Gas Price Slips Following Massive Inventory Addition
The U.S. Energy Information Administration reported Thursday morning that U.S. natural gas stocks increased more than expected for the week ending September 18.
How Caterpillar Plans to Deal With Slowing Markets
Caterpillar announced Thursday it plans a reorganization of its divisions across the company in an effort to improve efficiency and reduce complexity.
Jefferies Has 4 Stocks to Buy That Could Beat the Street on Q3 Earnings
Jefferies has revealed four distinctively different companies that have the potential to beat the consensus views.
8 Great Value Stocks With Solid Dividends Under 10 Times Earnings
After the sell-off, there are now many more solid and well-established dividend-paying companies valued at less than 10 times earnings.
Why Oppenheimer Says Alexion Is a Cheap Buy Now
Oppenheimer maintained its Outperform rating for Alexion Pharmaceuticals with a price target that implies upside of more than 40%.
Merrill Lynch Has 4 Pharma Stocks to Buy Against Political Chatter
One positive from the hammering the pharmaceutical stocks have taken is the Merrill Lynch analysts say investors have been given a golden opportunity to buy the top companies at much better prices.
Volkswagen Diesel Woes Cast Doubts on Other Makers’ Claims
A report Thursday morning claims that a BMW SUV spits out 11 times the amount of nitrogen oxide permitted new European standards.
Arrowhead Jumps in Anticipation of Analyst Day
Arrowhead Research shares soared in early trading indications Thursday in anticipation of its analyst day.